Skip to content

The Management of Neerizhivu(Diabetes mellitus) with Varma Manipulation and Neerizhivu kudineer

An Open Labeled Double Arm Non Randomised phase II Clinical Trial To Evaluate The Efficacy Of Varma Manipulation and Neerizhivu Kudineer In The Management Of Neerizhivu.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/026259
Enrollment
40
Registered
2020-06-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Varma: Varma Thadaval for 48 days Intervention2: Neerizhivu Kudineer: 90ml Internally twice a day Before food for 48 days Control Intervention1: Nil: Nil

Sponsors

Dr G Thirunarayanan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age above 30 and below 70 years (Both Sex) 2.Type II diabetes mellitus, previously diagnosed diabetic patients which are uncontrolled or poorly controlled for more than 2 years duration of the illness. 3.Patients whose fasting Blood Sugar is above 126 mg/dl and below 250mg/dl. 4. Patients whose Post Prandial Blood Sugar is above 200mg/dl and below 350mg /dl. 5.Patients whose HbA1c is above 6.5 and below 10 6.Patients with symptoms of polyuria, polydipsia, polyphagia, asthenia, nocturia, obesity (metabolic syndrome), numbness, tingling sensation, mood changes and irritability, difficulty in concentration. 7. Patient willing to give blood and urine sample before and after the treatment 8. Paients Willing to participate in Study and signing consent by fulfilling the condition of Proforma.

Exclusion criteria

Exclusion criteria: 1.Age below 30 years and above 70 years 2.Type I diabetes mellitus 3.Gestational DM 4. Other specific types of DM 5.Diabetes Insipidus 6.Pregnancy 7.Lactating mother 8.Chronic kidney disease / Renal failure 9.Chronic liver disease 10.Ischemic heart diseases 11.Other types of neuropathy

Design outcomes

Primary

MeasureTime frame
Maintenance of Optimal Blood Sugar LevelTimepoint: 48 days

Secondary

MeasureTime frame
Reduction of the signs and symptoms of Neerizhivu i.e, polyuria, polydipsia, polyphagia, asthenia, nocturia, numbness, tingling sensation, nausea, mood changes and irriability, difficulty in concentration. Achievement of optimal BMI.Timepoint: 48 days

Countries

India

Contacts

Public ContactDr S Sujatha

Government Siddha Medical College,Palayamkottai,Tirunelveli.

sujatharajasekar66@gmail.com9442331462

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026